Over 5 million Americans currently have the disease, and that number will climb dramatically as the baby boom generation ages. Millions more worldwide are afflicted with Alzheimer’s, threatening to overwhelm governments. A disease that slowly robs you of your mind can be especially cruel to its victims, but it also takes a heavy toll on families and caregivers as well.
So a treatment that can alter the course of the disease is desperately needed, yet so far there has only been failure and frustration. However, a drug called PBT2 is currently in clinical trials, and the anticipation is running high. PBT2 operates by a novel mechanism based on what has been called the Metal Hypothesis of Alzheimer’s. It’s believed that PBT2 can restore the natural balance of metals at the synapse of neurons damaged by Alzheimer’s disease.
If PBT2 is successful, it could be the start of a new era in the treatment of neurodegenerative disease. Long anticipated clinical trial results are due in early 2014. Anticipation is building and the stakes are high. Very high.
Are we on the verge of a medical breakthrough? The science is rock-solid and the early clues have been tantalizing. So read on, and stayed tuned.